![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, February 13, 2021 10:15:15 PM
Petemantx said,
I push this point often as I have not seen many (if anyone) making the strong point that BP shouldn't be given a carte blanche super percentage of the revenues with no clauses that escalate greatly the percentage IPIX reaps as revenues increase for our drugs.
Here’s one of my previous posts from 2/9/21...
After the Covid crisis has passed, I could see Leo signing with a BP to develop Brilacidin for innumerable diseases (bacterial, virus, parasitic, IBD, and perhaps even fungal or other conditions). But hopefully Leo is smart enough to negotiate a sliding scale of royalties that gets us to 50% after the gross reaches a billion or so.
I posted this on 2/9/21 in response to a post from HereToday proposing only 20% royalty...
20%? Absolutely not! If Brilacidin works against Covid, the governments of the world are going to write very large checks THIS YEAR. A big upfront payment is not worth much when the gross is going to dwarf the upfront payment in the short term. And giving 80% of the revenue to a “partner” who did NOTHING to get us to this point is an insult. Again, if Brilacidin works, we do NOT need a BP “partner”. We already contract the production and the finished product can be direct shipped to the appropriate address. All that remains is to deposit the checks (or just confirm that the proper funding was wired into our account).
"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."
Upton Sinclair
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM